Teprotumumab is associated with an increased risk of adverse events such as permanent deafness and autophony, according to ...
Researchers leveraged a large claims database to evaluate potential associations between thyroid eye disease and hearing loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback